TipRanks
Go Ultimate55% OFF

Eagle Pharmaceuticals (EGRX) Balance Sheet

Eagle Pharmaceuticals Balance Sheet

Eagle Pharmaceuticals's total assets for Q2 2023 were $404.82M, a decrease of 2.26% from the previous quarter. EGRX total liabilities were $152.78M for the fiscal quarter, a 10.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 22Dec 21Dec 20Dec 19Dec 18
$ 406.16M$ 253.73M$ 253.19M$ 254.55M$ 238.60M
$ 172.60M$ 77.28M$ 67.18M$ 75.38M$ 77.84M
$ 233.56M$ 176.45M$ 186.01M$ 179.17M$ 160.76M

Currency in USD

Eagle Pharmaceuticals Debt to Assets

0150M300M450M24 %32 %40 %48 %LiabilitiesDebt to Assets201720182019202020212022AssetsLiabilitiesDebt to Assets